Biogena Group Invest AG (WBO:BIO) Change In Receivables : €0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Change In Receivables?

Biogena Group Invest AG's change in receivables for the quarter that ended in Jan. 2024 was €0.00 Mil. It means Biogena Group Invest AG's Accounts Receivable stayed the same from Jan. 2023 to Jan. 2024 .

Biogena Group Invest AG's change in receivables for the fiscal year that ended in Jan. 2024 was €0.00 Mil. It means Biogena Group Invest AG's Accounts Receivable stayed the same from Jan. 2023 to Jan. 2024 .

Biogena Group Invest AG's Accounts Receivable for the quarter that ended in Jan. 2024 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Biogena Group Invest AG's Days Sales Outstanding for the six months ended in Jan. 2024 was 4.40.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Biogena Group Invest AG's liquidation value for the six months ended in Jan. 2024 was €-0.34 Mil.

Biogena Group Invest AG Change In Receivables Historical Data

The historical data trend for Biogena Group Invest AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Change In Receivables Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Change In Receivables

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Change In Receivables	-	-	-	-

Biogena Group Invest AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00 Mil.

Biogena Group Invest AG (WBO:BIO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Biogena Group Invest AG's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.004	/	0.166	*	91
=	4.40

2. In Ben Graham's calculation of liquidation value, Biogena Group Invest AG's accounts receivable are only considered to be worth 75% of book value:

Biogena Group Invest AG's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.023	-	0.366	+	0.75 * 0.004	+	0.5 * 0
=	-0.34

Biogena Group Invest AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.